abstract |
Disclosed is a compound of formula I, or a pharmaceutically acceptable salt or hydrate thereof, wherein R1 is CONR10SO2R6, R6 is C3-C6cycloalkyl, M is C1-12alkylene or C2-12alkenylene, and wherein the rest of the substituents are as defined in the specification. Also disclosed is the use of the compound for inhibiting HCV NS3 protease activity, or for treating HCV. |